Parexel

In this episode of @PharmTechGroup's Ask the Expert, Siegfried Schmitt explores a misconception: orphan drug development means less competition. He advises working closely with regulators and, if needed, to bring in external experts. Watch the video: brnw.ch/21x16TY

In celebration of Women's History Month, we are spotlighting Parexel co-founder Anne Sayigh. In an interview with Parexel CEO Peyton Howell, co-founder Josef von Rickenbach shares how he and Anne built Parexel together, her passion for science and her legacy. 🎥Watch below.

The landscape of breast cancer drug development has fundamentally shifted. Success requires more than traditional clinical operations—it demands precision in patient selection, regulatory harmonization and infrastructure. 🔗brnw.ch/21x0O8e

Parexel has been named the winner of the 2026 NEXT Award for Patient Leadership from @Medidata Solutions! Thank you to Medidata for this honor and for our shared effort to transform clinical research for patients everywhere.

Emerging regions are proving they can lead more rare disease research. They're expanding access, accelerating timelines, reaching treatment-naive groups and delivering quality data. Learn how they're rethinking research and why it's critical in @ACROhealth:brnw.ch/21x0zXj

Happy 115th International Women's Day! At Parexel, we're committed to fostering environments where all genders thrive. This year's #IWD2026 theme, #GivetoGain, reminds us that investing in women's advancement benefits everyone and we all have the power to make a difference.

For 400 million patients globally, clinical trials aren't just research opportunities—they're the ONLY care option available. But geographic disparities create a devastating paradox: those who need trials most often can't access them. Read in @ACROhealth: brnw.ch/21x0pDI

Parexel wins the @TriangleBIZJrnl's 2026 Space Award for Top Interior Space/Build-Out Project! Proud to call Raleigh's North Hills Innovation District home as we build the future of clinical research in innovative spaces!

In #ScripAsks Andreas Lysandropoulos shares insights on long-term data in neuroscience trials highlighting why organizational readiness—not just algorithms—will define the competitive advantage in 2026. insights.citeline.com/scrip/scrip-as…

Through our partnership with United Way Bengaluru, Parexel seeks to improve lives and strengthen communities in India. This past week, our CEO, Peyton Howell, was able to witness the impact of these initiatives. We see hope restored, confidence built and futures being reshaped.

Parexel wishes you a Happy New Year as we celebrate The Year of the Horse! We want to thank our colleagues for their extraordinary success, progress and dedication to improving the lives of patients everywhere. We look forward to what the new year brings!

Last week, Parexel Chief Executive Officer Peyton Howell began a nine‑day tour across India, one of our most important global locations. The visit was anchored around discussions with ACRO and invitations for Peyton to present at ISCR and the Global Business Summit. More to come!

More than 400,000 children develop cancer each year. Many lack access to life-saving treatment. We're committed to: ✓ Accelerating breakthrough pediatric treatments ✓ Expanding access to oncology trials ✓ Reducing inequalities in cancer care

Sponsors are evaluating their outsourcing models to reach operational excellency. In this @Clin_Trials article, Parexel's Kerri McCaul-Claus and Bristol Myers Squibb's Allison Covucci share how sponsors can transition without hurting quality or timelines📖appliedclinicaltrialsonline.com/view/developin…

According to Parexel's Jenny Denney, EVP, Global Head of FSP, sponsors are moving beyond the full-service outsourcing (FSO) vs. functional-service provider (FSP) debate and embracing more tailored hybrid models. See more predictions for biopharma in Scrip: insights.citeline.com/scrip/scrip-as…

Congratulations to our four colleagues recognized with With Heart™ awards! 🎉These awards recognize Parexel colleagues who demonstrate exceptional leadership, live our Core Values and behaviors and always deliver With Heart. 💖 #WithHeart #ProudToBeParexel

A recent NIHR case study highlights how Parexel supported two pivotal U.K. vaccine trials—for norovirus and influenza—achieving exemplary timelines. Read how it was done: brnw.ch/21wZIVa

This February is the 100th anniversary of Black History Month in the U.S. As we honor this centennial, we're proud of our resource group, Black Employees Advisory Consortium (BEACON), and its work to create change and we're committed to continuing this important journey together.

How do we think the clinical trial industry's usage of real-world data and real-world evidence will evolve over the year? We asked SVP, Global Head Real World Research Mike D'Ambrosio and he forecasts major impacts across the board.🌦️ 🔮Read through his predictions below! ⬇️

From micro to macro levels, Parexel's Chief Patient Officer, Stacy Hurt predicts that patient empowerment will continue to grow in 2026. 📈 Watch to learn how Stacy sees the patient's role in healthcare evolving from greater self-advocacy to gaining industry-wide recognition ➡️